| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $15,459,349 ) (Continued on the next page) |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM144046 | Regulation of protein multi-functionality by 3 UTRs | 000 | 5 | NIH | 12/15/2025 | $637,200 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA296688 | Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization | 000 | 2 | NIH | 1/6/2026 | $185,131 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MH135403 | Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals | 000 | 3 | NIH | 12/2/2025 | $706,519 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 000 | 7 | NIH | 12/11/2025 | $411,861 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD020111 | Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) | 000 | 2 | NIH | 1/2/2026 | $673,652 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01ES036297 | Structural basis of eukaryotic clamp loading | 001 | 3 | NIH | 1/1/2026 | $654,396 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM088253 | Template-based replication of the centriole organelle | 000 | 16 | NIH | 1/19/2026 | $351,370 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI182389 | Small-Molecule Penetration and Efflux in Gram-Negative Bacteria | 000 | 3 | NIH | 1/16/2026 | $1,203,141 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG087529 | Mechanisms and therapeutic potential of the autophagy-lysosome pathway in Alzheimer’s disease | 000 | 2 | NIH | 12/18/2025 | $783,983 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI100874 | The natural killer cell response against mouse cytomegalovirus infection | 000 | 14 | NIH | 12/8/2025 | $630,290 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI130345 | Development of the resident macrophage lineage in mouse and human | 000 | 9 | NIH | 1/9/2026 | $698,261 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI034206 | Self-Peptides Bound to MHC Class II in T Cell Selection | 000 | 32 | NIH | 11/26/2025 | $698,720 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG080684 | Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease | 000 | 4 | NIH | 12/3/2025 | $718,002 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA269733 | TOX-driven CD8 T cell differentiation and dysfunction in tumors | 000 | 4 | NIH | 12/30/2025 | $542,566 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA266068 | Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism | 000 | 4 | NIH | 12/17/2025 | $518,111 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA258622 | Ferroptosis and Cancer Cell Signaling | 000 | 5 | NIH | 1/19/2026 | $411,339 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA278599 | Mechanisms of racial disparity in breast cancer-related lymphedema | 000 | 4 | NIH | 1/16/2026 | $661,096 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K08CA259161 | Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation | 000 | 5 | NIH | 1/16/2026 | $250,379 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K00CA284294 | Engineering Biomaterials to Modulate the Tumor Immune Microenvironment | 000 | 4 | NIH | 1/20/2026 | $94,288 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA286111 | Backup DNA repair in homologous recombination deficient cancers | 000 | 2 | NIH | 12/5/2025 | $438,654 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA296335 | The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response | 000 | 2 | NIH | 1/14/2026 | $525,576 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA297077 | Metabolic control of malignant fates in lung cancer | 000 | 2 | NIH | 12/5/2025 | $657,361 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01AI187049 | Anti-ceramide Ab Preserves Intestinal Stem Cells and Prevents GI-ARS and GI-DEARE | 000 | 2 | NIH | 1/7/2026 | $616,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA261183 | Immune control and genomic instability at micronuclei | 000 | 5 | NIH | 12/23/2025 | $424,822 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA271186 | Probabilistic Multiscale Modeling of the Tumor Microenvironment | 000 | 4 | NIH | 12/17/2025 | $622,736 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA295658 | Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining | 000 | 2 | NIH | 12/11/2025 | $606,609 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA276946 | Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer | 000 | 4 | NIH | 12/9/2025 | $462,767 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA290231 | Targeting isocitrate dehydrogenase mutations by enzyme hyperactivation | 000 | 3 | NIH | 1/14/2026 | $427,285 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA214255 | Quantitative Sciences Summer Undergraduate Research Experience (QSURE) | 000 | 9 | NIH | 12/11/2025 | $102,666 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA286330 | Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial | 000 | 2 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA277464 | Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life | 000 | 2 | NIH | 12/29/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01ES036297 | Structural basis of eukaryotic clamp loading | 000 | 2 | NIH | 12/31/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01DK128615 | Genetic susceptibility to Barrett's esophagus: From GWAS to biology | 000 | 4 | NIH | 11/10/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG067598 | Chaperome networks in Alzheimer's disease | 000 | 5 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99AI175599 | Unraveling the ecology of intestinal fungal expansion in immunocompromised patients through computational modeling and machine learning | 000 | 2 | NIH | 11/17/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99CA276804 | Targeting Pancreatic Cancer Senescence with ImmunoPET | 000 | 2 | NIH | 12/30/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | P30CA008748 | Cancer Center Support Grant | 000 | 59 | NIH | 12/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | P30CA008748 | Cancer Center Support Grant | 000 | 59 | NIH | 12/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | P50CA271357 | MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe | 000 | 4 | NIH | 12/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA193837 | Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | 000 | 10 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AR068128 | Mechanisms and Function of Myonuclear Positioning | 000 | 10 | NIH | 11/11/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA244233 | Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin | 000 | 5 | NIH | 11/4/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA255655 | Genomic biomarkers of splenic lymphoma | 000 | 6 | NIH | 10/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K08CA252633 | Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes | 000 | 5 | NIH | 1/2/2026 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | UG1CA233332 | ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC) | 001 | 6 | NIH | 1/20/2026 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U54CA137788 | 2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach | 001 | 17 | NIH | 1/12/2026 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U54CA137788 | 2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach | 000 | 17 | NIH | 11/17/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01CA271287 | Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer | 000 | 4 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | T32CA254875 | Molecular Imaging in Cancer Biology Training Program | 000 | 5 | NIH | 12/2/2025 | $0 |
|
